NG Biotech is a French innovative biotech company developing & manufacturing novel in vitro diagnostic tools for Therapy Monitoring at the Point of Care (Onsite).
The company, founded by pioneers of the rapid test industry, has developed a proprietary patented immunoassay platform enabling the development of qualitative and multiplex point of care diagnostics. Results are obtained in few minutes from a single drop of blood (or any other type of sample).
NG Biotech founders are experienced scientists pioneers of the rapid test industry since the 1980s. While main lateral flow companies are still working in a yes/no answer approach; NG Biotech was founded to bring a new Quantitative and Multiplex Dimension to the rapid test industry with its patent pending innovative platform.